Skip to Main Content

Paper Details

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
J Affect Disord
26
2023
COMP360, TRD, anxiety, depression, life-threatening illness, major depression, participants, patient, patients, psilocybin, treatment-resistant depression
Author NameAffiliation
Jair C SoaresUT Houston Medical School
Allan H YoungInstitute of Psychiatry, King's College London, UK South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital
Allan H YoungInstitute of Psychiatry, King's College London, UK South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital
Sidney ZisookUniversity of California San Diego
  • 1 - 4

Datasets

Release 1.2